Bartosz Wasag, Els Lierman, Peter Meeus, Jan Cools, and Peter Vandenberghe. 2011. “The Kinase Inhibitor TKI258 Is Active Against the Novel CUX1-FGFR1 Fusion Detected in a Patient With T-Lymphoblastic leukemia/lymphoma and t(7;8)(q22;P11)”. Haematologica 96 (6). Pavia, Italy, 922-26. https://doi.org/10.3324/haematol.2010.036558.